The specialty of the treating physician affects the likelihood of tumor-free resection margins for basal cell carcinoma: Results from a multi-institutional retrospective study - 02/09/11
Abstract |
Background: Basal cell carcinoma (BCC) is the most common cutaneous malignancy. Surgical experience and physician specialty may affect the outcome quality of surgical excision of BCC. Methods: We performed a multicenter retrospective study of BCC excisions submitted to the respective Departments of Pathology at 4 major university medical centers. Our outcome measure was presence of histologic evidence of tumor present in surgical margins of excision specimens (incomplete excision). Clinician experience was defined as the number of excisions that a clinician performed during the study interval. The analytic sample pool included 1459 tumors that met all inclusion and exclusion criteria. Analyses included univariate and multivariate techniques involving the entire sample and separate subsample analyses that excluded 2 outlying dermatologists. Results: Tumor was present at the surgical margins in 243 (16.6%) of 1459 specimens. A patient's sex, age, and tumor size were not significantly related to the presence of tumor in the surgical margin. Physician experience did not demonstrate a significant difference either in the entire sample (P < .09) or in the subsample analysis (P > .30). Tumors of the head and neck were more likely to be incompletely excised than truncal tumors in all the analyses (P < .03). Compared with dermatologists, otolaryngologists (P < .02) and plastic surgeons (P < .008) were more likely to incompletely excise tumors; however, subsample analysis for plastic surgeons found only a trend toward significance (P < .10). Dermatologists and general surgeons did not differ in the likelihood of performing an incomplete excision (P > .4). Conclusion: The physician specialty may affect the quality of care in the surgical management of BCC. (J Am Acad Dermatol 2001;44:224-30.)
Le texte complet de cet article est disponible en PDF. Supported by Bristol-Myers Squibb Center for Dermatology Research. |
Vol 44 - N° 2
P. 224-229 - février 2001 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?